Use of ivermectin in the treatment of Covid-19: a pilot trial

DOI record: { "DOI": "10.1016/j.toxrep.2021.03.003", "ISSN": [ "2214-7500" ], "URL": "http://dx.doi.org/10.1016/j.toxrep.2021.03.003", "alternative-id": [ "S2214750021000445" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "RETRACTED: Use of ivermectin in the treatment of Covid-19: A pilot trial" }, { "label": "Journal Title", "name": "journaltitle", "value": "Toxicology Reports" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.toxrep.2021.03.003" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 The Authors. Published by Elsevier B.V." } ], "author": [ { "affiliation": [], "family": "Pott-Junior", "given": "Henrique", "sequence": "first" }, { "affiliation": [], "family": "Paoliello", "given": "Mˆonica Maria Bastos", "sequence": "additional" }, { "affiliation": [], "family": "Miguel", "given": "Alice de Queiroz Constantino", "sequence": "additional" }, { "affiliation": [], "family": "da Cunha", "given": "Anderson Ferreira", "sequence": "additional" }, { "affiliation": [], "family": "de Melo Freire", "given": "Caio Cesar", "sequence": "additional" }, { "affiliation": [], "family": "Neves", "given": "F´abio Fernandes", "sequence": "additional" }, { "affiliation": [], "family": "da Silva de Av´o", "given": "Lucimar Retto", "sequence": "additional" }, { "affiliation": [], "family": "Roscani", "given": "Meliza Goi", "sequence": "additional" }, { "affiliation": [], "family": "dos Santos", "given": "Sigrid De Sousa", "sequence": "additional" }, { "affiliation": [], "family": "Chach´a", "given": "Silvana Gama Florêncio", "sequence": "additional" } ], "container-title": "Toxicology Reports", "container-title-short": "Toxicology Reports", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 3, 10 ] ], "date-time": "2021-03-10T02:22:06Z", "timestamp": 1615342926000 }, "deposited": { "date-parts": [ [ 2022, 4, 29 ] ], "date-time": "2022-04-29T13:47:28Z", "timestamp": 1651240048000 }, "indexed": { "date-parts": [ [ 2024, 4, 8 ] ], "date-time": "2024-04-08T20:34:19Z", "timestamp": 1712608459861 }, "is-referenced-by-count": 32, "issued": { "date-parts": [ [ 2021 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 1, 1 ] ], "date-time": "2021-01-01T00:00:00Z", "timestamp": 1609459200000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 66, "start": { "date-parts": [ [ 2021, 3, 8 ] ], "date-time": "2021-03-08T00:00:00Z", "timestamp": 1615161600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2214750021000445?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2214750021000445?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "505-510", "prefix": "10.1016", "published": { "date-parts": [ [ 2021 ] ] }, "published-print": { "date-parts": [ [ 2021 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "The Battle against COVID 19 pandemic: what we need to know Before we \"test fire\" ivermectin", "author": "Banerjee", "first-page": "337", "issue": "August (8)", "journal-title": "Drug Res. (Stuttg)", "key": "10.1016/j.toxrep.2021.03.003_bib0005", "volume": "70", "year": "2020" }, { "DOI": "10.21873/invivo.12134", "article-title": "Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2", "author": "Lehrer", "doi-asserted-by": "crossref", "first-page": "3023", "issue": "September-October(5)", "journal-title": "In Vivo", "key": "10.1016/j.toxrep.2021.03.003_bib0010", "volume": "34", "year": "2020" }, { "article-title": "Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-alpha with in-vitro effective drug ivermectin", "author": "Sen Gupta", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "10.1016/j.toxrep.2021.03.003_bib0015", "volume": "28", "year": "2020" }, { "DOI": "10.1080/07391102.2020.1852117", "article-title": "Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2", "author": "Siddiqui", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "J. Biomol. Struct. Dyn.", "key": "10.1016/j.toxrep.2021.03.003_bib0020", "volume": "5", "year": "2020" }, { "DOI": "10.1016/j.antiviral.2020.104787", "article-title": "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro", "author": "Caly", "doi-asserted-by": "crossref", "journal-title": "Antiviral Res", "key": "10.1016/j.toxrep.2021.03.003_bib0025", "volume": "178", "year": "2020" }, { "article-title": "Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19", "author": "Pena-Silva", "journal-title": "Br. J. Clin. Pharmacol.", "key": "10.1016/j.toxrep.2021.03.003_bib0030", "volume": "17", "year": "2020" }, { "key": "10.1016/j.toxrep.2021.03.003_bib0035", "series-title": "Control C-CfD, Prevention. CDC 2019-Novel Coronavirus (2019-Ncov) Real-Time RT-PCR Diagnostic Panel", "year": "2020" }, { "DOI": "10.1038/s41467-020-19057-5", "article-title": "SARS-CoV-2 viral load is associated with increased disease severity and mortality", "author": "Fajnzylber", "doi-asserted-by": "crossref", "first-page": "5493", "issue": "October (1)", "journal-title": "Nat. Commun.", "key": "10.1016/j.toxrep.2021.03.003_bib0040", "volume": "11", "year": "2020" }, { "DOI": "10.1038/s41591-020-0869-5", "article-title": "Temporal dynamics in viral shedding and transmissibility of COVID-19", "author": "He", "doi-asserted-by": "crossref", "first-page": "672", "issue": "May(5)", "journal-title": "Nat. Med.", "key": "10.1016/j.toxrep.2021.03.003_bib0045", "volume": "26", "year": "2020" }, { "DOI": "10.1016/j.jinf.2020.06.067", "article-title": "SARS-CoV-2 detection, viral load and infectivity over the course of an infection", "author": "Walsh", "doi-asserted-by": "crossref", "first-page": "357", "issue": "September (3)", "journal-title": "J. Infect.", "key": "10.1016/j.toxrep.2021.03.003_bib0050", "volume": "81", "year": "2020" }, { "DOI": "10.1208/s12248-007-9000-9", "article-title": "The pharmacokinetics and interactions of ivermectin in humans--a mini-review", "author": "Gonzalez Canga", "doi-asserted-by": "crossref", "first-page": "42", "issue": "1", "journal-title": "AAPS J", "key": "10.1016/j.toxrep.2021.03.003_bib0055", "volume": "10", "year": "2008" }, { "article-title": "Interactions of potential anti-COVID-19 compounds with multispecific ABC and OATP drug transporters", "author": "Telbisz", "issue": "January 9", "journal-title": "Pharmaceutics", "key": "10.1016/j.toxrep.2021.03.003_bib0060", "volume": "13", "year": "2021" }, { "DOI": "10.1016/j.toxrep.2020.12.013", "article-title": "Nicotinic cholinergic system and COVID-19: in silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions", "author": "Alexandris", "doi-asserted-by": "crossref", "first-page": "73", "journal-title": "Toxicol. Rep.", "key": "10.1016/j.toxrep.2021.03.003_bib0065", "volume": "8", "year": "2021" }, { "article-title": "Nicotinic cholinergic system and COVID-19: in silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-v and SARS-CoV-2 spike glycoproteins", "author": "Lagoumintzis", "issue": "January 24", "journal-title": "Food Chem. Toxicol.", "key": "10.1016/j.toxrep.2021.03.003_bib0070", "volume": "149", "year": "2021" }, { "DOI": "10.1007/s00011-011-0307-8", "article-title": "Anti-inflammatory effects of ivermectin in mouse model of allergic asthma", "author": "Yan", "doi-asserted-by": "crossref", "first-page": "589", "issue": "June (6)", "journal-title": "Inflamm. Res.", "key": "10.1016/j.toxrep.2021.03.003_bib0075", "volume": "60", "year": "2011" }, { "DOI": "10.1007/s00011-008-8007-8", "article-title": "Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "524", "issue": "November (11)", "journal-title": "Inflamm. Res.", "key": "10.1016/j.toxrep.2021.03.003_bib0080", "volume": "57", "year": "2008" }, { "DOI": "10.1016/j.onehlt.2020.100148", "article-title": "COVID-19 and the rush for self-medication and self-dosing with ivermectin: a word of caution", "author": "Molento", "doi-asserted-by": "crossref", "journal-title": "One Health", "key": "10.1016/j.toxrep.2021.03.003_bib0085", "volume": "10", "year": "2020" }, { "DOI": "10.1371/journal.pone.0242184", "article-title": "Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients", "author": "Camprubi", "doi-asserted-by": "crossref", "issue": "11", "journal-title": "PLoS One", "key": "10.1016/j.toxrep.2021.03.003_bib0090", "volume": "15", "year": "2020" }, { "article-title": "Use of ivermectin Is associated with Lower mortality in hospitalized patients with coronavirus disease 2019: the ICON study", "author": "Rajter", "issue": "October 13", "journal-title": "Chest", "key": "10.1016/j.toxrep.2021.03.003_bib0095", "year": "2020" }, { "article-title": "A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness", "author": "Ahmed", "first-page": "214", "issue": "December 2", "journal-title": "Int. J. Infect. Dis.", "key": "10.1016/j.toxrep.2021.03.003_bib0100", "volume": "103", "year": "2020" }, { "DOI": "10.18433/jpps31457", "article-title": "Therapeutic potential of ivermectin as add on treatment in COVID 19: a systematic review and meta-analysis", "author": "Padhy", "doi-asserted-by": "crossref", "first-page": "462", "journal-title": "J. Pharm. Pharm. Sci.", "key": "10.1016/j.toxrep.2021.03.003_bib0105", "volume": "23", "year": "2020" }, { "DOI": "10.1371/journal.pone.0247163", "article-title": "Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: a matched case-control study", "author": "Behera", "doi-asserted-by": "crossref", "issue": "2", "journal-title": "PLoS One", "key": "10.1016/j.toxrep.2021.03.003_bib0110", "volume": "16", "year": "2021" } ], "reference-count": 22, "references-count": 22, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2214750021000445" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Health, Toxicology and Mutagenesis", "Toxicology" ], "subtitle": [], "title": "RETRACTED: Use of ivermectin in the treatment of Covid-19: A pilot trial", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "update-to": [ { "DOI": "10.1016/j.toxrep.2021.03.003", "label": "Retraction", "type": "retraction", "updated": { "date-parts": [ [ 2021, 1, 1 ] ], "date-time": "2021-01-01T00:00:00Z", "timestamp": 1609459200000 } } ], "volume": "8" }